Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by rollthedice10on Nov 20, 2024 10:41am
173 Views
Post# 36321668

RE:RE:RE:RE:2025 Outlook

RE:RE:RE:RE:2025 Outlook Well, to get into the big leagues which is where TLT is headed for,
you need big resourses, distribution chains, larger R&D , etc etc.
Building a better mousetrap that you can't get to market would indeed
be failure. Structuring the JV will be critical so that both sides win.
The only way I would like to see a buyout would be a cash/shares
offering to shareholders.. Cash, plus shares in the " Parent " Company.
Either way they go it will require some carefully thought out negotiations
with thought to future earnings being paramount. Also the patents.. Who will
hold them? Complicated process ahead and I hope TLT will if nessesary
hire some expertise in this these areas to guide the process. This could
be HUGE and we want to make sure TLT is not taken advantage of in
the structuring of a JV or buyout. JMO, I'm not an expert but I have been
around enough to see deals that work and deals that don't.
<< Previous
Bullboard Posts
Next >>